Shilpa Ravindran

605 citations
11 papers · 395 indexed · 1 hit paper · h-index 7
Topics
MicroRNA in disease regulation (2 papers)Cancer Cells and Metastasis (2 papers)Immunotherapy and Immune Responses (2 papers)
Partner nations
IndiaUnited StatesQatar

In The Last Decade

Shilpa Ravindran

11 papers receiving 384 citations

Hit Papers

Procalcitonin: a promising diagnostic marker for sepsis a...20172026202020232017100200300

Peers

Shilpa Ravindran
Comparison fields: 5 of 94
  • Epidemiology 176
  • Molecular Biology 79
  • Oncology 65
  • Surgery 59
  • Public Health, Environmental and Occupational Health 58
Replace Sara Cajander with:
Sara Cajander Sweden
Diana Tilevik Sweden
M Průcha Czechia
Nils‐Olivier Olsson France
Darci R Block United States
Yanhong Jia China
Teresa Rushing United States
E. Scott Halstead United States
Irene T. Schrijver Switzerland
Sangeeta Mehta Canada
Shilpa Ravindran relative to Sara Cajander Sweden Sara Cajander's profile →
Citations per field
00.5×1.5×2.5×
Sara Cajander · 1×
Citations per year

Countries citing papers authored by Shilpa Ravindran

Since Specialization
Citations

This map shows the geographic impact of Shilpa Ravindran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpa Ravindran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpa Ravindran more than expected).

Fields of papers citing papers by Shilpa Ravindran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpa Ravindran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpa Ravindran. The network helps show where Shilpa Ravindran may publish in the future.

Co-authorship network of co-authors of Shilpa Ravindran

This figure shows the co-authorship network connecting the top 25 collaborators of Shilpa Ravindran. A scholar is included among the top collaborators of Shilpa Ravindran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilpa Ravindran. Shilpa Ravindran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 1
2 4
3 1
4 13
5 10
6 35
7 10
8 6
9
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapybreakdown →
304
10 5
11 6

About Shilpa Ravindran

Shilpa Ravindran is a scholar working on Critical Care and Intensive Care Medicine, Clinical Biochemistry and Immunology, having authored 11 papers that have together received 395 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Cancer Cells and Metastasis (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (49 citations), Epidemiology (176 citations) and Clinical Biochemistry (28 citations). Shilpa Ravindran has collaborated with scholars based in India, United States and Qatar. Frequent co-authors include R. Saikant, Kartik Ravishankar, G. Manoj, S Lakshmi, Cristina Maccalli, Sara Tomei, Stefania Mazzoleni, Ena Wang, Soldano Ferrone and Rossella Galli. Their work appears in journals such as Vaccine, Cancers and Cytokine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026